查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1225339

mRNA 疫苗和 mRNA 治疗市场：2023-2028 年全球行业趋势、份额、规模、增长、机遇和预测

mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

到 2022 年，全球 mRNA 疫苗和疗法的市场规模将达到 561 亿美元。 展望未来，IMARC Group 预计到 2028 年将达到 662 亿美元，2023 年至 2028 年的增长率 (CAGR) 为 2.9%。

信使核糖核酸 (mRNA) 是指基因组中的单个蛋白质编码基因，是细胞内蛋白质合成的基础。 mRNA 疫苗和治疗剂结合了理想的免疫学特性，并在实验室中使用哺乳动物细胞製备。 常见的疫苗和疗法包括自我扩增、非复制、体内自我复制和体外树突细胞非复制 mRNA。 这些被注入体内，激活检测病毒的免疫传感器，并在细胞中产生病毒抗原蛋白。 这可以改善 B 细胞和 T 细胞的反应并增强身体的免疫力。

糖尿病、结核病、癌症和心血管疾病 (CVD) 等疾病患病率上升是推动市场增长的关键因素之一。 对埃博拉、流感和人类免疫缺陷病毒 (HIV) 等病毒感染的治疗药物和疫苗的需求不断增长，也推动了市场增长。 与常规药物相比，mRNA 疫苗和治疗剂对病原体更有效，具有更高的效力和免疫原性，并且正在使用成本效益相对较高的先进技术进行开发。 此外，用于体内全身递送mRNA的脂质纳米颗粒製剂的改进也为市场带来了光明的前景。 製药公司正在投资 mRNA 技术，因为它允许将多个分子组合成治疗药物，这也是主要的增长动力。 其他因素，如生物技术领域的广泛研发 (R&D) 活动和医疗保健技术的改进，预计将进一步推动市场。

主要市场细分

  • 在其 mRNA 疫苗和治疗药物的全球市场报告中，IMARC Group 提供了 2023 年至 2028 年全球、区域和国家层面的预测，以及每个子细分市场的主要趋势分析。 该报告根据疫苗类型、治疗类型、疫苗生产、应用、最终用户等对市场进行分类。

按疫苗类型分类

  • 基于自扩增 mRNA 的疫苗
  • 传统的未扩增的基于 mRNA 的疫苗

按治疗类型细分

  • 生物基因疫苗
  • 基因疗法
  • 基因转移
  • 细胞疗法
  • 单克隆抗体
  • 其他

疫苗生产细目

  • 内部
  • 外包

按应用细分

  • 癌症
  • 感染
  • 基因编辑
  • 蛋白质替代品

最终用户细分

  • 医院和诊所
  • 研究所
  • 其他

按地区划分

  • 北美
  • 美国
  • 加拿大
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚
  • 印度尼西亚
  • 其他
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 意大利
  • 西班牙
  • 俄罗斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中东和非洲

内容

第一章前言

第 2 章研究方法和范围

  • 调查的目的
  • 利益相关者
  • 数据来源
    • 主要信息
    • 次要信息
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章执行摘要

第四章介绍

  • 概览
  • 主要行业趋势

第 5 章 mRNA 疫苗和治疗学简介

  • mRNA 疫苗和药物开发的历史
  • 慢性病和主要传染病的患病率和患病率
  • 通过 mRNA 疫苗/治疗剂进行预防和治疗
    • mRNA 修饰
    • mRNA 效率
    • mRNA 疫苗的佐剂、激活剂和载体技术
    • 使用 mRNA 的蛋白质/抗体药物载体

第 6 章 mRNA 疫苗和治疗药物的全球市场

  • 市场潜力概览
  • 市场潜力
  • COVID-19 的影响
  • 研发中的 mRNA 疫苗

第 7 章疫苗类型市场细分

  • 基于自扩增 mRNA 的疫苗
  • 传统的未扩增的基于 mRNA 的疫苗

第 8 章按治疗类型划分的市场细分

  • 基因治疗
  • 单克隆抗体
  • 基因转录
  • 细胞疗法
  • 生物技术疫苗
  • 其他

第 9 章疫苗製造的市场细分

  • 内部
  • 外包

第 10 章按应用划分的市场细分

  • 癌症
  • 感染
  • 基因编辑
  • 蛋白质替代品

第 11 章最终用户的市场细分

  • 医院和诊所
  • 研究所
  • 其他

第 12 章区域市场细分

  • 北美
    • 按国家/地区划分的市场细分
      • 美国
      • 加拿大
  • 欧洲
    • 按国家/地区划分的市场细分
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 俄罗斯
      • 其他
  • 亚太地区
    • 按国家/地区划分的市场细分
      • 日本
      • 中国
      • 澳大利亚
      • 韩国
      • 印度
      • 印度尼西亚
      • 其他
  • 拉丁美洲
    • 按国家/地区划分的市场细分
      • 巴西
      • 墨西哥
      • 其他
  • 中东和非洲
    • 按国家/地区划分的市场细分

第 13 章 SWOT 分析

  • 概览
  • 强度
  • 弱点
  • 机会
  • 威胁

第14章价值链分析

第15章波特五力分析

  • 概览
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第16章竞争格局

  • 市场结构
  • 主要公司
  • 主要公司简介
    • Arcturus Therapeutics, Inc.
    • BioNTech SE
    • CureVac AG
    • eTheRNA immunotherapies NV
    • ethris GmbH
    • GlaxoSmithKline PLC
    • Moderna Therapeutics Inc.
    • Translate Bio Inc.
    • Argos Therapeutics, Inc.
    • Sangamo Therapeutics Inc.
    • Pfizer Inc.
Product Code: SR1423A180_Report

The global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.2 Billion by 2028, exhibiting a growth rate (CAGR) of 2.9% during 2023-2028.

Messenger Ribonucleic Acid (mRNA) refers to a single protein-coding gene in the genome that acts as a basis for protein synthesis within the cells. mRNA vaccines and therapeutics combine the desirable immunological properties and are prepared in laboratories using mammalian cells. Some of the common types of vaccines and therapeutics include self-amplifying, non-replicating, in vivo self-replicating and in vitro dendritic cell non-replicating mRNA. They are injected into the body to trigger virus-detecting immune sensors and produce viral antigen proteins within the cells. This aids in enhancing the body's immunity by improving B- and T-cell responses.

The rising prevalence of medical ailments, such as diabetes, tuberculosis, cancer and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the market. The increasing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections is also providing a boost to the market growth. In comparison to conventional medicines, mRNA vaccines and therapeutics are developed using advanced technologies that are more effective against pathogens, have higher potency, enhanced immunogenicity and are relatively more cost-effective. Additionally, improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market. Pharmaceutical companies are investing in mRNA technologies as they can combine multiple molecules into a therapeutic medicine, which is acting as another major growth-inducing factor. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with improvements in the healthcare technologies, are projected to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global mRNA vaccines and therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, treatment type, vaccine manufacturing, application and end-user.

Breakup by Vaccine Type:

  • Self-amplifying mRNA-Based Vaccines
  • Conventional Non-Amplifying mRNA-Based Vaccines

Breakup by Treatment Type:

  • Bioengineered Vaccine
  • Gene Therapy
  • Gene Transcription
  • Cell Therapy
  • Monoclonal Antibody
  • Others

Breakup by Vaccine Manufacturing:

  • In-House
  • Out-Sourced

Breakup by Application:

  • Cancer
  • Infectious Disease
  • Gene Editing
  • Protein Replacement

Breakup by End-User:

  • Hospitals and Clinics
  • Research Organizations
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Arcturus Therapeutics Inc., BioNTech SE, CureVac AG, eTheRNA immunotherapies NV, ethris GmbH, GlaxoSmithKline PLC, Moderna Therapeutics Inc., Translate Bio Inc., Argos Therapeutics, Inc., Sangamo Therapeutics Inc. and Pfizer Inc, etc.
  • Key Questions Answered in This Report
  • 1. What was the size of the global mRNA vaccines and therapeutics market in 2022?
  • 2. What is the expected growth rate of the global mRNA vaccines and therapeutics market during 2023-2028?
  • 3. What are the key factors driving the global mRNA vaccines and therapeutics market?
  • 4. What has been the impact of COVID-19 on the global mRNA vaccines and therapeutics market?
  • 5. What is the breakup of the global mRNA vaccines and therapeutics market based on the vaccine type?
  • 6. What is the breakup of the global mRNA vaccines and therapeutics market based on the treatment type?
  • 7. What is the breakup of the global mRNA vaccines and therapeutics market based on vaccine manufacturing?
  • 8. What is the breakup of the global mRNA vaccines and therapeutics market based on the application?
  • 9. What is the breakup of the global mRNA vaccines and therapeutics market based on the end-user?
  • 10. What are the key regions in the global mRNA vaccines and therapeutics market?
  • 11. Who are the key players/companies in the global mRNA vaccines and therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Introduction to mRNA Vaccines and Therapeutics

  • 5.1 History of mRNA Vaccines and Therapeutics Development
  • 5.2 Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases
  • 5.3 Prevention and Treatment Using mRNA Vaccines and Therapeutics
    • 5.3.1 mRNA Modifications
    • 5.3.2 mRNA Efficiencies
    • 5.3.3 Adjuvant/Stimulant and Carrier Technologies for mRNA-Based Vaccines
    • 5.3.4 Carriers for mRNA-Based Protein and Antibody Therapeutics

6 Global mRNA Vaccines and Therapeutics Market

  • 6.1 Market Potential Overview
  • 6.2 Market Potential
  • 6.3 Impact of COVID-19
  • 6.4 mRNA Vaccines in Pipeline

7 Market Breakup by Vaccine Type

  • 7.1 Self-amplifying mRNA-Based Vaccines
  • 7.2 Conventional Non-Amplifying mRNA-Based Vaccines

8 Market Breakup by Treatment Type

  • 8.1 Gene Therapy
  • 8.2 Monoclonal Antibody
  • 8.3 Gene Transcription
  • 8.4 Cell Therapy
  • 8.5 Bioengineered Vaccine
  • 8.6 Others

9 Market Breakup by Vaccine Manufacturing

  • 9.1 In-House
  • 9.2 Out-Sourced

10 Market Breakup by Application

  • 10.1 Cancer
  • 10.2 Infectious Disease
  • 10.3 Gene Editing
  • 10.4 Protein Replacement

11 Market Breakup by End-User

  • 11.1 Hospitals and Clinics
  • 11.2 Research Organizations
  • 11.3 Others

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 Market Breakup by Country
      • 12.1.1.1 United States
      • 12.1.1.2 Canada
  • 12.2 Europe
    • 12.2.1 Market Breakup by Country
      • 12.2.1.1 Germany
      • 12.2.1.2 United Kingdom
      • 12.2.1.3 France
      • 12.2.1.4 Italy
      • 12.2.1.5 Spain
      • 12.2.1.6 Russia
      • 12.2.1.7 Others
  • 12.3 Asia Pacific
    • 12.3.1 Market Breakup by Country
      • 12.3.1.1 Japan
      • 12.3.1.2 China
      • 12.3.1.3 Australia
      • 12.3.1.4 South Korea
      • 12.3.1.5 India
      • 12.3.1.6 Indonesia
      • 12.3.1.7 Others
  • 12.4 Latin America
    • 12.4.1 Market Breakup by Country
      • 12.4.1.1 Brazil
      • 12.4.1.2 Mexico
      • 12.4.1.3 Others
  • 12.5 Middle East and Africa
    • 12.5.1 Market Breakup by Country

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Arcturus Therapeutics, Inc.
    • 16.3.2 BioNTech SE
    • 16.3.3 CureVac AG
    • 16.3.4 eTheRNA immunotherapies NV
    • 16.3.5 ethris GmbH
    • 16.3.6 GlaxoSmithKline PLC
    • 16.3.7 Moderna Therapeutics Inc.
    • 16.3.8 Translate Bio Inc.
    • 16.3.9 Argos Therapeutics, Inc.
    • 16.3.10 Sangamo Therapeutics Inc.
    • 16.3.11 Pfizer Inc.

List of Figures

  • Figure 1: Global: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 2: Global: mRNA Vaccines and Therapeutics Market Potential (Self-amplifying mRNA-Based Vaccines): Value Trends (in Billion US$), 2023-2028
  • Figure 3: Global: mRNA Vaccines and Therapeutics Market Potential (Conventional Non-Amplifying mRNA-Based Vaccines): Value Trends (in Billion US$), 2023-2028
  • Figure 4: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Therapy): Value Trends (in Billion US$), 2023-2028
  • Figure 5: Global: mRNA Vaccines and Therapeutics Market Potential (Monoclonal Antibody): Value Trends (in Billion US$), 2023-2028
  • Figure 6: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Transcription): Value Trends (in Billion US$), 2023-2028
  • Figure 7: Global: mRNA Vaccines and Therapeutics Market Potential (Cell Therapy): Value Trends (in Billion US$), 2023-2028
  • Figure 8: Global: mRNA Vaccines and Therapeutics Market Potential (Bioengineered Vaccine): Value Trends (in Billion US$), 2023-2028
  • Figure 9: Global: mRNA Vaccines and Therapeutics Market Potential (Other Treatment Types): Value Trends (in Billion US$), 2023-2028
  • Figure 10: Global: mRNA Vaccines and Therapeutics Market Potential (In-House): Value Trends (in Billion US$), 2023-2028
  • Figure 11: Global: mRNA Vaccines and Therapeutics Market Potential (Out-Sourced): Value Trends (in Billion US$), 2023-2028
  • Figure 12: Global: mRNA Vaccines and Therapeutics Market Potential (Cancer): Value Trends (in Billion US$), 2023-2028
  • Figure 13: Global: mRNA Vaccines and Therapeutics Market Potential (Infectious Disease): Value Trends (in Billion US$), 2023-2028
  • Figure 14: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Editing): Value Trends (in Billion US$), 2023-2028
  • Figure 15: Global: mRNA Vaccines and Therapeutics Market Potential (Protein Replacement): Value Trends (in Billion US$), 2023-2028
  • Figure 16: Global: mRNA Vaccines and Therapeutics Market Potential (Hospitals and Clinics): Value Trends (in Billion US$), 2023-2028
  • Figure 17: Global: mRNA Vaccines and Therapeutics Market Potential (Research Organizations): Value Trends (in Billion US$), 2023-2028
  • Figure 18: Global: mRNA Vaccines and Therapeutics Market Potential (Other End-Users): Value Trends (in Billion US$), 2023-2028
  • Figure 19: North America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 20: North America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 21: United States: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 22: Canada: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 23: Europe: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 24: Europe: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 25: Germany: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 26: United Kingdom: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 27: France: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 28: Italy: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 29: Spain: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 30: Russia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 31: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 32: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 33: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 34: Japan: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 35: China: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 36: Australia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 37: South Korea: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 38: India: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 39: Indonesia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 40: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 41: Latin America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 42: Latin America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 43: Brazil: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 44: Mexico: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 45: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2023-2028
  • Figure 46: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2023-2028
  • Figure 47: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2022
  • Figure 48: Global: mRNA Vaccines and Therapeutics Industry: SWOT Analysis
  • Figure 49: Global: mRNA Vaccines and Therapeutics Industry: Value Chain Analysis
  • Figure 50: Global: mRNA Vaccines and Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: mRNA Vaccines and Therapeutics Market Potential: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: mRNA Vaccines and Therapeutics Market: List of Pipeline mRNA Vaccines
  • Table 3: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Type (in Billion US$), 2023-2028
  • Table 4: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Treatment Type (in Billion US$), 2023-2028
  • Table 5: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Manufacturing (in Billion US$), 2023-2028
  • Table 6: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Application (in Billion US$), 2023-2028
  • Table 7: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by End-User (in Billion US$), 2023-2028
  • Table 8: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Region (in Billion US$), 2023-2028
  • Table 9: Global: mRNA Vaccines and Therapeutics Market: Competitive Structure
  • Table 10: Global: mRNA Vaccines and Therapeutics Market: List of Key Players